AMPIVIEW® RNA probes
Enabling Your Projects 
GMP Services
Bulk Solutions
Research Travel Grant
Have You Published Using an Enzo Product?
- Increased stability
- Enhanced immune activation compared to other recombinant ligands
- Mimics glycosylation of native human FasL
SUPERFASLIGAND® (soluble) (human), (recombinant) features an N-terminus linker shown to improve stability and enhance immune activation compared to recombinant ligands alone.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
SDS-PAGE analysis: Lane 1: MW Marker, Lane 2: 1μg SuperFasL, stained with Imperial stain.
Jurkat Cell Death: 50,000 Jurkat cells per well are incubated with the indicated concentration of SuperFasL for 3 hours. Cell death is determined by Cell-titer AQueous one-solution cell proliferation reagent. Formazan product is allowed to develop for 6 hours before the plate is read at 490nm. % Viability is determined in comparison to control well with no SuperFasL.
| Regulatory Status |
RUO – Research Use Only |
|---|
Resources
Metabolism
Download Resource
Cellular Therapy
Download Resource
Cardiovascular Research
Download Resource
Drug Discovery
Download Resource
AMPIVIEW® RNA Probes
Download Resource
Immuno-Oncology
Download Resource
AMPIGENE® PCR Solutions
Download Resource
Bioprocess
Download ResourceRelated Products
KillerTRAIL™ Protein (soluble) (human), (recombinant)
ALX-201-073
Enhanced ligand that utilizes the proprietary Killer™ linker peptide that promotes stability.
| Alternative Name | Apo-2L, TNFSF 10, CD253 |
|---|---|
| Purity | ≥99% (SDS-PAGE, MS analysis) |
| Source | Produced in E. coli. The extracellular domain of human TRAIL (aa 95-281) is fused at the N-terminus to a His-tag and a linker peptide. |
SUPERKILLERTRAIL® Protein (soluble) (human), (recombinant)
ALX-201-115
Enhanced ligand with improved stability providing significantly enhanced immune activation.
| Alternative Name | TNFSF 10, Apo-2L, CD253 |
|---|---|
| Purity | ≥98% (SDS-PAGE). MS analysis, <1% impurity (mainly Hsp70 protein from E. coli) |
| Source | Produced in E. coli. The extracellular domain of human TRAIL (aa 95-281) is fused at the N-terminus to a His-tag and a linker peptide. The active multimeric conformation is stabilized by an inserted mutation allowing an additional CC-bridge. |
| Alternative Name | Tumor necrosis factor-α, TNFSF 2 |
|---|---|
| Purity | ≥97% (SDS-PAGE) |
| Source | Produced in yeast. |
MEGACD40L® Protein (soluble) (human), (recombinant)
ALX-522-110
High activity, high purity CD40L protein for co-stimulatory activation of an immune response
| Alternative Name | CD40L:ACRP30headless, CD154:ACRP30headless, TNFSF 5:ACRP30headless, gp39:ACRP30headless |
|---|---|
| Purity | ≥90% (SDS-PAGE) |
| Source | Produced in CHO cells. The extracellular domain of human CD40L (CD154) (aa 116-261) is fused at the N-terminus to mouse ACRP30headless (aa 18-111) and a FLAG®-tag. |